🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Antineoplastic Drugs in Elderly Patients

Recruitingn/aAges 65 Years - 100 YearsAllShandong University
NCT05467189 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose is to study the population pharmacokinetics, effectiveness and safety of antineoplastic drugs (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib, Imatinib, Lapatinib, etc) in elderly patients and recommend optimized dosage regimens.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Subjects must meet all of the following inclusion criteria to be enrolled in the study: 1. Age ≥65 years old; 2. Diagnosed with cancer; 3. Using antineoplastic drugs for treatment. Exclusion Criteria: Subjects with any of the following criteria will not be enrolled in this study: 1. Patients who are expected to die within 48 hours; 2. Patients with allergy to antineoplastic drugs; 3. Patients receiving other investigational drugs; 4. Other factors that the researcher considers unsuitable for inclusion.
💊

What it tests

  • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
📍

Where

1 site
Shandong Provincial Qianfoshan Hospital
Jinan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy